MicroA AS has been awarded 6.7 MNOK from the Norwegian Research Councils Innovation Project for the Industrial Sector program for the project “Prasinoguard: Safe and effective novel therapeutic for the treatment of respiratory disorders.”
The project aims to provide the healthcare community with natural, safe, efficacious and sustainable molecules to treat respiratory conditions using our microalgae derived biopolymers.